SHANGHAI, CHINA -- PHARMA UPDATE NEWS SERVICE™ -- SEPTEMBER 2, 2014: The Fourth Asia Pacific Pharmaceutical Compliance Congress, www.AsianPharmaCongress.com, September 16 - 18, 2014, will be held in Shanghai, China at the Intercontinental Shanghai Pudong Hotel. The Asia Pacific Pharma Congress is sponsored by the Asia Pacific Healthcare Industry Compliance Team and cosponsored by the International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and the Pharmaceutical Compliance Forum. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Abdul Luheshi, MBA Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Congress, London, UK David Snow, MBA President, China and Hong Kong, AstraZeneca, Shanghai, China Veronique Toully, MBA, DVM Managing Director, China, UCB, Shanghai, China Kin Ping Tsang Chair, International Alliance of Patients Organizations (IAPO), Founder, Retina Hong Kong, Past Chair, Alliance for Patients Mutual Help Organizations (APMHO), Hong Kong Professor Huang Yong Competition Law Center, University of International Business and Economics, Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, Peoples Republic of China, Beijing, China Shirley Zhao, MBA President, Allergan China, Shanghai, China

FEATURING PRECONFERENCE Negotiating, Implementing, Managing, Auditing and Monitoring Third Party Relationships PLENARY SESSIONS Asia Pacific Pharma Congress Vision and Overview Perspectives from the C-Suite: Ethical Business Practice Asia Pacific Compliance Issues from a Global Perspective Asia Pacific Stakeholders Roundtable: HCPs, Hospitals and Patients Key Issues Overview/Mini Summit Preview China's Health System and How it is Being Reformed The Chinese Anti-unfair Competition Law Overview of Recent Chinese Laws and Regulations Chinese Compliance Best Practices Roundtable Enhancing the Professional Role of a Compliance Officer Asia Pacific R&D and Clinical Trials Compliance Third Party Relationships Roundtable New Pharma Business Models New Compliance Challenges AND MINI SUMMITS Training on Compliance and Ethics Basics: Program Basics Hot Asia Pac Compliance Issues Country Compliance Updates: Malaysia and Indochina Building the Compliance Profession Advanced Issues in Anticorruption Compliance Training on Compliance and Ethics Basics: Core Compliance Risks Country Compliance Updates: Myanmar, India and Indonesia Investigations Updates Public Procurement, Tendering, Reimbursement and Pricing Update The Role of Forensics in Compliance Training on Compliance and Ethics Basics: Evolving Issues, Rising Expectations Compliance Best Practices Country Compliance Updates: Korea, Japan and Taiwan Social Media and Technology Tools for Compliance ASIA PACIFIC PHARMA CONGRESS IS

FEATURED FACULTY

Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Masood Ahmed Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore Timothy Ayers, JD, MPH Principal, Porzio, Bromberg & Newman, Morristown, NJ, USA Cheryl Bai, Esq. Associate General Counsel, Greater China, Allergan Inc., Shanghai, China Dane Chamorro Managing Director, Control Risks South-east Asia, Singapore Eugene Chen, Esq. Partner, Shanghai Office, Hogan Lovells International LLP, Shanghai, China Iona Cheng Practice Leader, Integrity Risk Consulting, Greater China and North Asia, Shanghai, China Kherk Ying Chew, Esq. Managing Partner, Wong & Partners, An affiliate of Baker & McKenzie, Kuala Lumpur, Malaysia Chester Chu, CPA, CFE, CGMA Director, Fraud Investigation & Dispute Services, EY, Taipei, Taiwan Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea Yee Chung Seck, Esq. Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Socialist Republic of Vietnam Sangeet Dalliwall, LLB, LLM Director of Compliance, APAC, Carlson Wagonlit Travel, Singapore Damjan P. DeNoble, JD, MA Partner, Rubicon Strategy Group, Editor, Health Intel Asia, Seattle, WA, USA Sanjay Dhawan Pharma GRC Leader; Executive Director, Risk Advisory Services, PwC, Bangalore, India Carole Ducrest, Esq. Regional General Counsel, APAC, China, Japan, Merck KGaA, Singapore Lars Eckerlein Partner, Fraud Investigation & Dispute Services, Ernst & Young, Beijing, China Benjamin Ee Associate Director, PwC, Singapore Adrian Emch, LLM Partner, Hogan Lovells International LLP, Beijing, China Cahyani Endahayu Associate Partner, Hadiputranto, Hadinoto & Partners, An affiliate of Baker & McKenzie, Jakarta, Indonesia James Finch, Esq. Partner and Head of Myanmar Office, DFDL/Myanmar Thanlwin Legal Services Ltd., Yangon, Myanmar Steven N. Gersten, Esq. Vice President, Ethics & Compliance Officer, International and Global Marketing, AbbVie, Former Divisional Vice President and Associate General Counsel, Commercial Legal Operations, Abbott Laboratories, Chicago, IL, USA Dario Ghoddousi Senior Vice President of Global Transparency and Master Data Management Solutions, Cegedim Relationship Management, Paris, France Michelle Y.L. Gon, Esq. Partner, Baker & McKenzie, Shanghai Erinn Hutchinson Partner, Advisory Services, PricewaterhouseCoopers Consultants (Shenzhen) Limited, Shanghai, China Sandy S. Johnston Partner, PwC, Shanghai, China Kitchrat Kontain, LLM, MBA Managing Partner, South East Asia Law Office, Vientiane, Laos Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Cristopher Landrito, LIB Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore Dominique Laymand Vice President Compliance & Ethics EMEA, (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, President, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France Ren Jun Lim Partner, Baker & Mckenzie, Singapore Lei Li, LLB, LLM Partner, Sidley Austin LLP, Beijing, China Steffanie Lim-Ho Head of Ethics & Compliance, Lilly China, Shanghai, China Chia-Feng Lu, Esq. Associate, Baker & McKenzie (Gaikokuho Joint Enterprise), Tokyo, Japan Andrew Martin, Esq. Principal, Baker & McKenzie, Wong & Leow, Singapore Shawn McBride Vice President & General Manager - Direct to Patient and Market Access, Cardinal Health, Shanghai, China Ramesh Moosa Partner, Forensic Technology Solutions, PwC, Shanghai, China Dinesh Moudgil Executive Director, EY, Mumbai, Maharashtra, India Clement Ngai, Esq. Partner, Baker & McKenzie Shanghai Office, Shanghai, China Sun Qiang Deputy Dean, Assistant Professor, Center for Health Management and Policy, School of Public Health, Shandong University, Jinan, China Teng Ren, MA Head of Compliance, Asia-Pacific, Middle East, and Africa, Russia/Ukraine, Novartis, Former Compliance Director, Johnson & Johnson Medical China and Eli Lilly, Singapore Brian Riewerts Principal, Global Governance, Risk and Compliance Leader, Pharmaceutical and Life Sciences Advisory, PwC, Baltimore, MD, USA Bretton G. Sciaroni, Esq. Partner, Sciaroni & Associates, Phnom Penh, Cambodia Clarissa SHEN, MBA Country Compliance Officer, Global Compliance and Business Ethics, Sanofi, Shanghai, China Benjamin Shobert, MBA Partner and Founder, Rubicon Strategy Group, Seattle, WA Yuthana Sivaraks Partner, Baker & McKenzie Ltd., Bangkok, Thailand John Tan, Esq. Counsel, Reed Smith, Former China Regional Compliance Director, Pfizer, Shanghai, China Julie Tan Senior Compliance Manager, AstraZeneca, Shanghai, China Rhys Tee Associate Director, Compliance (APAC), Allergan, Singapore John Tsai Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China Emmanuel Vignal Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China Kevin Y. H. Wang, LLM Senior Consultant, Baker & McKenzie, Taipei, Taipei, Taiwan Wendy L. Wysong, Esq. Partner, Clifford Chance LLP, Former Assistant US Attorney, Washington, DC, Former Deputy Assistant Secretary for Export Enforcement, Bureau of Industry & Security, UA Department of Commerce, Hong Kong and Washington, DC, USA Chen Yang, Esq. Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China Shine Yao, MIM China Compliance Director, Merck Sharp & Dohme, Shanghai, China Eva Yin Vice President, Commercial AstraZeneca China, Former China/HK Compliance Officer, AstraZeneca, Shanghai, China Eric Young Forensic Technology Partner, EY, Hong Kong Bing Yu, LLB, LLM Of Counsel, Clifford Chance LLP, Shanghai, China Zhu Yuanyuan, LLM Partner, King & Wood Malleson, Beijing, China Richard Yun Partner, King & Wood Malleson, Beijing, China Stella Zhu, LLM Senior Counsel, Asia Pacific for R&D, Allergan, Shanghai, China

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.


The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

• Accounting Professionals: Approved for up to 17.0 NASBA CPE credits.
• Compliance Professionals: Approved for up to 22.2 Compliance Certification Board CCB Credits.
• Attorneys: Approved to offer a maximum of 17.00 Hours of California CLE Credit. The Congress is currently pending approval to offer Pennsylvania MCLE Credit.